Oriol Borrega

Oriol Borrega

Auto-generated profile, based on publicly available information

Oriol Borrega

Òmada Interactiva, SLL, Barcelona, Spain

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 March 2021 in JMIR Formative Research
Verified
Journal Article
Open access
RRRoxana Radu
Roxana Radu
SHSara Hernández-Ortega
Sara Hernández-Ortega
OBOriol Borrega
Oriol Borrega
VSVolker Straub
Volker Straub
DADimitrios Athanasiou
Dimitrios Athanasiou
BEBegonya Nafria Escalera
Begonya Nafria Escalera
Background: Rare disease communities are spread around the globe and segmented by their condition. Little research has been performed on the majority of rare diseases. Most patients who are affected by a rare disease have no research on their condition because of a lack of knowledge due to absence of common groups in the research community. Objective: We aimed to develop a safe and secure community of rare disease patients, without geographic or language barriers, to promote research. Methods: Cocreation design methodology was applied to build Share4Rare, with consultation and input through workshops from a variety of stakeholders (patients, caregivers, clinicians, and researchers). Results: The workshops allowed us to develop a layered version of the platform based on educating patients and caregivers with publicly accessible information, a secure community for the patients and caregivers, and a research section with the purpose of collecting patient information for analysis, which was the core and final value of the platform. Conclusions: Rare disease research requires global collaboration in which patients and caregivers have key roles. Collective intelligence methods implemented in digital platforms reduce geographic and language boundaries and involve patients in a unique and universal project. Their contributions are essential to increase the amount of scientific knowledge that experts have on rare diseases. Share4Rare has been designed as a global platform to facilitate the donation of clinical information to foster research that matters to patients with rare conditions. The codesign methods with patients have been essential to create a patient-centric design.

14 April 2026 in Interactive Journal of Medical Research
Verified
Journal Article
Open access
CMCarlota de Miquel
Carlota de Miquel
CFChristina M. Van Der Feltz-Cornelis
Christina M. Van Der Feltz-Cornelis
LRLeona Hakkaart-Van Roijen
Leona Hakkaart-Van Roijen
DMDorota Merecz-Kot
Dorota Merecz-Kot
MSMarjo Sinokki
Marjo Sinokki
BOBeatriz Olaya
Beatriz Olaya
Background: Occupational e-mental health (OeMH) interventions emerged as a promising solution to prevent common mental health problems and enhance well-being and work performance. However, they must be subject to robust and reliable assessments for effectiveness. Methods: A multimodal e-mental health intervention (EMPOWER [The European Platform to Promote Wellbeing and Health in the Workplace]) delivered over 7 weeks was developed and evaluated through a cluster randomized controlled trial conducted mainly in small to medium enterprises and public agencies from Spain (n=127), Finland (n=141), Poland (n=51), and the United Kingdom (n=389) between February 2022 and May 2024 (recruitment finalized in September 2023 and follow-up completed in May 2024). Inclusion criteria were being 18+ years, having a smartphone, sufficient language knowledge, and agreeing to participate. Clusters (companies or departments) were randomized to intervention or control conditions. The primary outcome was presenteeism, and secondary outcomes were depression and anxiety symptoms, etc, all measured at baseline, postintervention, and in 21 weeks after program completion. The analysis was performed as an intention-to-treat approach using adjusted linear mixed models and as per protocol analysis comparing outcomes by level of engagement. Results: A total of 347 participants were allocated to the intervention group and 361 to the control group. In the overall sample, the intention-to-treat analysis detected no statistically significant short-term (7 wk) or long-term (21 wk postintervention) effects of the EMPOWER intervention on presenteeism (postintervention β =2.186; 95% CI −2.424 to 6.796, follow-up β =1.294; 95% CI −3.608 to 6.396) and on other secondary outcomes such as depressive symptoms (postintervention β =−0.052, 95% CI −1.02 to 0.905, follow-up β =0.202, 95% CI −0.840 to 1.245), anxiety symptoms (postintervention β =−0.328, 95% CI −1.168 to 0.512, follow-up β =0.375, 95% CI −0.537 to 1.287), or general stress level (postintervention β =0.385, 95% CI −0.195 to 0.965, follow-up β =0.123, 95% CI −0.502 to 0.749). Subgroup analyses yielded several notable results, with significant differences between age groups, gender, and psychological symptoms at baseline. The per-protocol analysis showed no significant differences between participants who actively engaged with the intervention (119/347, 34%) and those who did not. Implementation challenges were related to technical problems, the complexity of this study’s design, external factors, co-design strategy, and organizational barriers, which led to a smaller sample size, high attrition rates, and low adherence. Conclusions: Our study provides evidence from a large cluster randomized controlled trial evaluating an OeMH intervention implemented in workplace settings, including small to medium enterprises and public agencies in Europe. Although no overall effectiveness was observed, this study contributes important methodological and implementation insights, highlighting the challenges of evaluating OeMH interventions. These findings suggest that future interventions should prioritize feasibility testing, organizational readiness, user engagement, and more targeted and pragmatic evaluation approaches to enhance real-world impact.

21 July 2020 in JMIR Preprints
Verified
Preprint
Open access
RRRoxana Radu
Roxana Radu
SHSara Hernández-Ortega
Sara Hernández-Ortega
OBOriol Borrega
Oriol Borrega
VSVolker Straub
Volker Straub
DADimitrios Athanasiou
Dimitrios Athanasiou
BEBegonya Nafria Escalera
Begonya Nafria Escalera
BACKGROUND Rare disease communities are spread around the globe and segmented by their condition. Little research has been performed on the majority of rare diseases. Most patients who are affected by a rare disease have no research on their condition because of a lack of knowledge due to absence of common groups in the research community. OBJECTIVE We aimed to develop a safe and secure community of rare disease patients, without geographic or language barriers, to promote research. METHODS Cocreation design methodology was applied to build Share4Rare, with consultation and input through workshops from a variety of stakeholders (patients, caregivers, clinicians, and researchers). RESULTS The workshops allowed us to develop a layered version of the platform based on educating patients and caregivers with publicly accessible information, a secure community for the patients and caregivers, and a research section with the purpose of collecting patient information for analysis, which was the core and final value of the platform. CONCLUSIONS Rare disease research requires global collaboration in which patients and caregivers have key roles. Collective intelligence methods implemented in digital platforms reduce geographic and language boundaries and involve patients in a unique and universal project. Their contributions are essential to increase the amount of scientific knowledge that experts have on rare diseases. Share4Rare has been designed as a global platform to facilitate the donation of clinical information to foster research that matters to patients with rare conditions. The codesign methods with patients have been essential to create a patient-centric design.